Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for MR-107A-02 ...

Sun Pharma Advanced Research Company says Ocuvex Therapeutics received a USFDA Complete Response Letter for PDP-716, shares ...

Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced at the 2026 BIO-IT World Conference & Expo in Boston that the QIAGEN Digital Insights bioinformatics business and its curated knowledge ...

Investigational New Drug application for KHN921 received 'study may proceed” from the US FDA. KHN921 is a potential 'first-in-class' cardiovascular AAV gene therapy being developed for the treatment o ...

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a ...

President Donald Trump just announced that he was going to be adding more than 600 generic drugs to his federal ...

A step counter will not do the hard part of dieting for you. But new research suggests it may help with the part many people ...

Data demonstrate distinct functional signatures across MSC-derived extracellular vesicles supporting targeted regenerative and aesthetic ...

Australian, New Zealand and Pacific Island nations have agreed to co-ordinate maritime surveillance and interception of ...

The U.S. Food and Drug Administration's decision to withhold approval of a new skin cancer treatment fell like a hammer on ...